Recombinant extracellular domain (p75ECD) of the neurotrophin receptor p75 attenuates myocardial ischemia-reperfusion injury by inhibiting the p-JNK/caspase-3 signaling pathway in rat microvascular pericytes

Autor: Yunling Lin, ZhiXiong Wei, DanQing Hu, Teng Ying, DeDong Zheng, Lingzhen Wu, Xin-Fu Zhou, TingXiang Lan, Hong Huashan, Jun Fang, Lianglong Chen, ZhiWei Yang, XiaoLiang Jiang
Přispěvatelé: Fang, Jun, Wei, ZhiXiong, Zheng, DeDong, Ying, Teng, Hong, HuaShan, Hu, DanQing, Lin, YunLing, Jiang, XiaoLiang, Wu, LingZhen, Lan, TingXiang, Yang, ZhiWei, Zhou, XinFu, Chen, LiangLong
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
microvascular dysfunction
Myocardial Infarction
Apoptosis
Coronary Artery Disease
Receptor
Nerve Growth Factor

Ventricular Function
Left

law.invention
Rats
Sprague-Dawley

0302 clinical medicine
law
pericyte
Coronary Heart Disease
Phosphorylation
Receptor
Cells
Cultured

c-Jun N-terminal kinase
Original Research
0303 health sciences
biology
Ventricular Remodeling
Caspase 3
neurotrophin receptor
extracellular domain
reperfusion injury
Recombinant Proteins
Cell biology
medicine.anatomical_structure
Recombinant DNA
Pericyte
Signal transduction
c‐Jun N‐terminal kinase
Cardiology and Cardiovascular Medicine
Neurotrophin
Signal Transduction
Myocardial Reperfusion Injury
03 medical and health sciences
Extracellular
medicine
Animals
030304 developmental biology
business.industry
Myocardium
JNK Mitogen-Activated Protein Kinases
Recovery of Function
medicine.disease
Atherosclerosis
Fibrosis
Peptide Fragments
Disease Models
Animal

biology.protein
business
Pericytes
Reperfusion injury
030217 neurology & neurosurgery
Zdroj: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Popis: Background Pro‐NTs (precursor of neurotrophins) and their receptor p75 are potential targets for preventing microvascular dysfunction induced by myocardial ischemia–reperfusion injury ( IRI ). p75ECD (ectodomain of neurotrophin receptor p75) may physiologically produce neurocytoprotective effects by scavenging pro‐ NT s. We therefore hypothesized that p75 ECD may have a cardioprotective effect on IRI through microvascular mechanisms. Methods and Results Myocardial IRI was induced in Sprague‐Dawley rats by occluding the left main coronary arteries for 45 minutes before a subsequent relaxation. Compared with the ischemia–reperfusion group, an intravenous injection of p75 ECD (3 mg/kg) 5 minutes before reperfusion reduced the myocardial infarct area at 24 hours after reperfusion (by triphenyltetrazolium chloride, 44.9±3.9% versus 34.6±5.7%, P NT s expression at 24 hours and 28 days after reperfusion (by Western blotting). A simulative IRI model using rat microvascular pericytes was established in vitro by hypoxia–reoxygenation (2/6 hours) combined with pro‐ NT s treatment (3 nmol/L) at R. p75 ECD (3 μg/mL) given at R improved pericyte survival (by methyl thiazolyl tetrazolium assay) and attenuated apoptosis (by terminal deoxynucleotidyl transferase‐mediated dUTP‐biotin nick‐end labeling). In the reperfused hearts and hypoxia–reoxygenation +pro‐ NT s‐injured pericytes, p75 ECD inhibited the expression of p‐JNK (phospho of c‐Jun N‐terminal kinase)/caspase‐3 (by Western blotting). SP 600125, an inhibitor of JNK , did not enhance the p75 ECD ‐induced infarct‐sparing effects and pericyte protection. Conclusions p75 ECD may attenuate myocardial IRI via pro‐ NT s reduction‐induced inhibition of p‐ JNK /caspase‐3 pathway of microvascular pericytes in rats.
Databáze: OpenAIRE